Bill Gates Investing $40 Million for mRNA Vaccine Development in Africa



The Gates Foundation is spending $40 million on countries in Africa and other economically backward nations to produce new mRNA vaccines in efforts to prevent against diseases like tuberculosis and malaria.

On Monday, the Bill & Melinda Gates Foundation announced $40 million in funding to "advance access to mRNA research and vaccine manufacturing technology that will support low-and middle-income countries’ (LMICs) capacity to develop high-quality, lifesaving vaccines at scale," according to an Oct. 9 press release. The $40 million will be spent on boosting access to a low-cost mRNA research and manufacturing platform developed by Belgium-based Quantoom Biosciences.
While $20 million will go to Quantoom, two research institutes in Africa—located in Senegal and South Africa—will get $5 million each. The remaining $10 million will go to vaccine manufacturers from low- and middle-income countries.
Dr. Muhammad Ali Pate, Nigeria’s coordinating minister of health and social welfare and a global expert on vaccines, supported the investment by the Gates family.

“Putting innovative mRNA technology in the hands of researchers and manufacturers in Africa and around the world will help ensure more people benefit from next-generation vaccines. This collaboration is an encouraging step that will increase access to critical health technologies and help African countries develop vaccines that meet the needs of their people,” he said.

However, the evidence indicated that the Gates family doesn’t have good intentions.

It was previously reported that Bill Gates, with the approval of the Biden administration, released an army of genetically modified mosquitoes in the states of Florida and California, while also being suspected of doing a similar thing in Massachusetts.